hydroxyindoleacetic acid has been researched along with amantadine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (73.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pradhan, SN | 1 |
| Gray, MW; Herzberg, L; Lerman, JA; Turnbull, MJ; Victoratos, G | 1 |
| Cox, B; Tha, SJ | 1 |
| Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ | 1 |
| Chan, WW; Rausch, WD; Riederer, P; Schallauer, E; Weiser, M | 1 |
| Messiha, FS | 1 |
| Rinne, UK; Siirtola, T; Sonninen, V | 1 |
| Jones, DG; Lenman, JA; Robertson, MA; Turnbull, MJ | 2 |
| Ahtee, L; Kääriäinen, I; Paasonen, MK | 1 |
| Fodor, A; Molnár, G | 1 |
| Fujita, Y; Inagaki, C; Kimura, M; Shimada, S; Tanaka, C | 1 |
| Chase, TN; Glaubiger, GA; Woods, AC | 1 |
| Altagracia, M; Kravzov, J; Rios, C; Rojas, P | 1 |
| Antoniou, K; Daïfoti, Z; Vamvakidès, A | 1 |
1 review(s) available for hydroxyindoleacetic acid and amantadine
| Article | Year |
|---|---|
Aggression and central neurotransmitters.
Topics: Acetylcholinesterase; Aggression; Amantadine; Animals; Apomorphine; Brain; Carbachol; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine beta-Hydroxylase; Humans; Hydroxydopamines; Hydroxyindoleacetic Acid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parasympatholytics; Pimozide; Tubocurarine | 1975 |
2 trial(s) available for hydroxyindoleacetic acid and amantadine
| Article | Year |
|---|---|
Treatment of Parkinson's disease with amantadine and L-Dopa.
Topics: Adult; Aged; Alkaline Phosphatase; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Female; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Parkinson Disease; Phenylacetates; Placebos; Prognosis | 1972 |
Parkinson disease treated with a suspected dopamine receptor agonist.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Piperazines; Placebos; Probenecid; Pyrimidines; Receptors, Cholinergic; Tremor; Trihexyphenidyl | 1974 |
12 other study(ies) available for hydroxyindoleacetic acid and amantadine
| Article | Year |
|---|---|
Letter: Amantadine in chorea.
Topics: Aged; Amantadine; Chorea; Drug Evaluation; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid | 1975 |
Amantadin e tremor, a 5-hydroxytryptamine-mediated response?
Topics: Amantadine; Animals; Brain; Brain Chemistry; Fenclonine; Hydroxyindoleacetic Acid; Mice; Mice, Inbred Strains; Monoamine Oxidase; Reserpine; Serotonin; Stomach; Thiocarbamates; Tremor | 1975 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; Middle Aged; Movement Disorders; Parkinson Disease; Phenylacetates; Tremor | 1977 |
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Interactions; Female; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Parkinson Disease, Secondary; Selegiline; Serotonin | 1990 |
Genotype-treatment interaction between amantadine and chlorpromazine in the mouse.
Topics: Amantadine; Animals; Biogenic Amines; Brain; Chlorpromazine; Dopamine; Drug Interactions; Genotype; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Motor Activity; Normetanephrine; Serotonin; Time Factors | 1991 |
Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
Topics: Adult; Aged; Amantadine; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Histamine; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenylacetates | 1972 |
Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus.
Topics: Amantadine; Animals; Atropine; Body Temperature; Brain; Caudate Nucleus; Depression, Chemical; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methadone; Muscle Rigidity; Muscle Tonus; Nalorphine; Parasympatholytics; Phenylacetates; Rats; Serotonin; Spectrometry, Fluorescence; Trihexyphenidyl | 1972 |
Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
Topics: Amantadine; Amines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Histamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Norepinephrine; Parkinson Disease; Phenylacetates | 1972 |
Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
Topics: Amantadine; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Parkinson Disease; Phenylacetates | 1973 |
[Effect of amantadine on serotonin metabolism in the rat brain].
Topics: Administration, Oral; Amantadine; Animals; Brain; Brain Chemistry; Carbon Radioisotopes; Dopa Decarboxylase; Female; Hydroxyindoleacetic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nialamide; Rats; Serotonin | 1973 |
Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Parkinson Disease, Secondary; Probenecid; Serotonin | 1993 |
[Action mechanism of anticonvulsant and anti-immobility (forced swim) effects of 3', 4'-dihydro-N, N-dimethylspiro-[9H-fluorene-9, 2' (5'H) furane]-3'-methanamine (AE37F)].
Topics: Amantadine; Animals; Anticonvulsants; Brain Chemistry; Convulsants; Furans; Hydroxyindoleacetic Acid; Mice; Motor Activity; Muscarinic Antagonists; Pentylenetetrazole; Rats; Receptors, N-Methyl-D-Aspartate; Serotonin; Spiro Compounds; Swimming | 2004 |